Mesoblast reported 669.15M in Assets for its fiscal semester ending in June of 2024.


Assets Change Date
Avita Medical AUD 79.71M 8.12M Dec/2024
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Cochlear AUD 2.79B 41M Dec/2024
CSL USD 38.45B 425M Dec/2024
Pacific Edge NZD 37.03M 13.82M Mar/2025
Paradigm Biopharmaceuticals AUD 35.36M 7.97M Dec/2024
PYC Therapeutics AUD 68.23M 23.01M Dec/2024
Ramsay Health Care AUD 20.66B 237M Dec/2024
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Starpharma Holdings AUD 29.62M 7.2M Dec/2024
Telix Pharmaceuticals AUD 1.52B 770.47M Dec/2024